Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion type Assertion NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_head.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion description "[Consequently, the SKP2 pathway may be a suitable target for novel prostate cancer therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_provenance.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion evidence source_evidence_literature NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_provenance.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion SIO_000772 12188931 NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_provenance.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion wasDerivedFrom befree-2016 NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_provenance.
- NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_assertion wasGeneratedBy ECO_0000203 NP365164.RAKis6DEm4T9BKhxr8IFHt4Sqjg-DU1CQU6JBgXBiyhrk130_provenance.